Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone in Diabetic Nephropathy
NCT02689778Phase 3Completed
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Mar 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pirfenidone in diabetic nephropathy (DN), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Started Mar 2016; status: completed.
02
Drugs
pirfenidone
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02689778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02689778.